VAERS reports by lot

GSK Varicella/Shingles lot X5XY4: VAERS reports

31 VAERS reports list lot X5XY4 as a GSK Varicella/Shingles vaccine, received between 2019-02-17 and 2019-12-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
6%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3826%
General / Systemic (non-local)3020%
Dermatological (non-injection-site)2416%
Neurological1812%
Musculoskeletal139%
Cardiac / Cardiovascular107%
Allergic / Anaphylactic75%
Gastrointestinal64%
Respiratory21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan3
Virginia3
Indiana3
Iowa3
Pennsylvania3
Illinois2
Kentucky2
Florida2
South Carolina2
California1
Massachusetts1
North Dakota1

Reports by month received

2019-026
2019-0312
2019-046
2019-062
2019-082
2019-092
2019-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.